Effects of a 5 alpha-reductase inhibitor, finasteride, on the developing prostate and testis of a marsupial

被引:0
|
作者
Ryhorchuk, AR [1 ]
Shaw, G [1 ]
Butler, CM [1 ]
Renfree, MB [1 ]
机构
[1] UNIV MELBOURNE,DEPT ZOOL,PARKVILLE,VIC 3052,AUSTRALIA
来源
JOURNAL OF ANDROLOGY | 1997年 / 18卷 / 02期
关键词
virilization; Wolffian duct; tammar wallaby; androgen; dihydrotestosterone;
D O I
暂无
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
This study examines the role of dihydrotestosterone in virilization of the developing male tammar. The onset of prostate differentiation in this marsupial species normally occurs around 25 days postpartum, long after the onset of testicular testosterone production immediately after birth and the appearance of 5 alpha-reductase in the urogenital sinus before day 10. Males treated with the 5 alpha-reductase inhibitor Finasteride had reduced prostatic growth and development, and their testicular structure was disorganized. Exogenous testosterone in males enhanced the development of prostatic buds but also caused damage to the testis structure. Treatment of female tammars with testosterone between days 20-30 postpartum stimulated prostatic tissue formation and Wolffian duct development, confirming that prostatic differentiation is initiated by androgens and occurs over a relatively narrow window of time. Testosterone had a deleterious effect on the ovary, destroying the germ cells. Although treatment with testosterone damaged gonadal cellular structure in both male and female tammar young, dihydrotestosterone is apparently necessary for stability of the seminiferous tubules in the testis. Taken together, these results suggest that dihydrotostesterone initiates prostatic development between days 20 and 25 after birth in this marsupial.
引用
收藏
页码:123 / 130
页数:8
相关论文
共 50 条
  • [31] THE CLINICAL EFFECTS OF A 5-ALPHA-REDUCTASE INHIBITOR, FINASTERIDE, ON BENIGN PROSTATIC HYPERPLASIA
    STONER, E
    [J]. JOURNAL OF UROLOGY, 1992, 147 (05): : 1298 - 1302
  • [32] CLINICAL AND HORMONAL EFFECTS OF THE 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE IN IDIOPATHIC HIRSUTISM
    MOGHETTI, P
    CASTELLO, R
    MAGNANI, CM
    TOSI, F
    NEGRI, C
    ARMANINI, D
    BELLOTTI, G
    MUGGEO, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (04): : 1115 - 1121
  • [33] Effects of a new non-steroidal 5 alpha-reductase inhibitor, FK143, on the prostate gland in beagle dogs
    Inami, M
    Kawamura, I
    Naoe, Y
    Tsujimoto, S
    Mizota, T
    Manda, T
    Shimomura, K
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1997, 74 (02): : 187 - 194
  • [34] EVIDENCE FOR ATROPHY AND APOPTOSIS IN THE VENTRAL PROSTATE OF RATS GIVEN THE 5-ALPHA-REDUCTASE INHIBITOR FINASTERIDE
    RITTMASTER, RS
    MANNING, AP
    WRIGHT, AS
    THOMAS, LN
    WHITEFIELD, S
    NORMAN, RW
    LAZIER, CB
    ROWDEN, G
    [J]. ENDOCRINOLOGY, 1995, 136 (02) : 741 - 748
  • [35] Is DHT production by 5 alpha-reductase friend or foe in prostate cancer?
    Kosaka, Takeo
    Miyajima, Akira
    Oya, Mototsugu
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [36] Current Status of 5 alpha-Reductase Inhibitors in Prostate Disease Management
    Kang, Dong Il
    Chung, Jae Il
    [J]. KOREAN JOURNAL OF UROLOGY, 2013, 54 (04) : 213 - 219
  • [37] STEROID 5 ALPHA-REDUCTASE ACTIVITY OF RAT-LIVER AND PROSTATE
    ROY, AB
    [J]. BIOCHIMIE, 1971, 53 (09) : 1031 - &
  • [38] FINASTERIDE - THE 1ST 5-ALPHA-REDUCTASE INHIBITOR
    SUDDUTH, SL
    KORONKOWSKI, MJ
    SHARIFI, R
    LEE, M
    CALI, TJ
    CHAMBERLAIN, TM
    [J]. PHARMACOTHERAPY, 1993, 13 (04): : 309 - 329
  • [39] FINASTERIDE - A SLOW-BINDING 5-ALPHA-REDUCTASE INHIBITOR
    FALLER, B
    FARLEY, D
    NICK, H
    [J]. BIOCHEMISTRY, 1993, 32 (21) : 5705 - 5710
  • [40] Evaluation of Sex Hormone Levels in Benign Prostatic Hyperplasia Patients Treated with 5 Alpha-Reductase Inhibitor (Finasteride) in Amara city/Iraq
    Hashim, Nidhal A.
    Khalifa, Ahmed A.
    Mohammed, Mukhtar K.
    [J]. BAGHDAD SCIENCE JOURNAL, 2020, 17 (01) : 1 - 8